SCHEMBL4372628

SCHEMBL4372628

Cc1c(CO)cc(C=O)cc1CO

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.39
ALDH1A1 P00352 2/20 0.39
MEN1 O00255 1/20 0.39
LMNA P02545 1/20 0.39
HPGD P15428 1/20 0.39
KMT2A Q03164 1/20 0.39
AOX1 Q06278 1/20 0.39
TRIM24 O15164 1/20 0.38
TRIM33 Q9UPN9 1/20 0.38
SRC P12931 2/20 0.37
CYP2A6 P11509 1/20 0.36
SHBG P04278 1/20 0.32
PTGS2 P35354 1/20 0.32
RAB9A P51151 1/20 0.32
ERN1 O75460 1/20 0.32
MAOA P21397 2/20 0.32
MAOB P27338 2/20 0.32
PDCD1 Q15116 1/20 0.31
CD274 Q9NZQ7 1/20 0.31
GRIA1 P42261 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16560287 0.83 ALDH1A1 (0.46) KDM4EALDH1A1HPGDAOX1TRIM24
SCHEMBL13643406 0.79 KDM4E (0.36) KDM4EALDH1A1MEN1LMNAHPGD
SCHEMBL21632238 0.79 KDM4E (0.43) KDM4EALDH1A1MEN1LMNAHPGD
SCHEMBL13306818 0.77 CYP1A2 (0.47) KDM4EALDH1A1MEN1LMNAHPGD
SCHEMBL4367756 0.77 KDM4E (0.42) KDM4EALDH1A1MEN1LMNAHPGD
SCHEMBL29954339 0.75 KDM4E (0.54) KDM4EALDH1A1MEN1LMNAHPGD
SCHEMBL19499649 0.75 SRC (0.49) KDM4EALDH1A1HPGDAOX1TRIM24
SCHEMBL27871739 0.73 SRC (0.46) KDM4EALDH1A1MEN1LMNAHPGD
SCHEMBL2601956 0.73 KDM4E (0.46) KDM4EALDH1A1HPGDAOX1TRIM24
SCHEMBL19411067 0.72 ERN1 (0.42) KDM4EALDH1A1MEN1LMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120107886-A1 Lignin Oxidation and Products Thereof STRATEGIC ENZYME APPLICATIONS, INC. (US) 2012-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120107886-A1 Lignin Oxidation and Products Thereof LOX, LPO, NOX4 KDM4E 512/4885ALDH1A1 263/4885MEN1 4885/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.